RT Journal Article
SR Electronic
T1 SARS-CoV-2 Genomic Surveillance Reveals Little Spread Between a Large University Campus and the Surrounding Community
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.19.21260726
DO 10.1101/2021.07.19.21260726
A1 Andrew L. Valesano
A1 William J. Fitzsimmons
A1 Christopher N. Blair
A1 Robert J. Woods
A1 Julie Gilbert
A1 Dawn Rudnik
A1 Lindsey Mortenson
A1 Thomas C. Friedrich
A1 David H. O’Connor
A1 Joshua G. Petrie
A1 Emily T. Martin
A1 Adam S. Lauring
YR 2021
UL http://medrxiv.org/content/early/2021/07/22/2021.07.19.21260726.abstract
AB COVID-19 has had high incidence at institutions of higher education (IHE) in the United States, but the transmission dynamics in these settings are not well understood. It remains unclear to what extent IHE-associated outbreaks have contributed to transmission in nearby communities. We implemented high-density prospective genomic surveillance to investigate these dynamics at the University of Michigan-Ann Arbor and the surrounding community during the Fall 2020 semester (August 16th –November 24th). We sequenced complete SARS-CoV-2 genomes from 1659 individuals, including 468 students, representing 20% of cases in students and 25% of total confirmed cases in Washtenaw County over the study interval. Phylogenetic analysis identified over 200 introductions into the student population, most of which were not related to other student cases. There were two prolonged transmission clusters among students that spanned across multiple on-campus residences. However, there were very few genetic descendants of student clusters among non-students during a subsequent November wave of infections in the community. We conclude that outbreaks at the University of Michigan did not significantly contribute to the rise in Washtenaw County COVID-19 incidence during November 2020. These results provide valuable insights into the distinct transmission dynamics of SARS-CoV-2 among IHE populations and surrounding communities.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was not a clinical trialFunding StatementThis work was funded by CDC contract 75D30120C09870.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Use of residual SARS-CoV-2 positive specimens and collection of student status and on-campus residence were approved by the Institutional Review Board at the University of Michigan (Protocol HUM185966).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe consensus genomes we generated for this study are publicly available on GISAID. Accessions for these sequences as well as other genomes from GISAID used in these analyses are listed in Supplementary Table 1. Analysis code for the generation of consensus sequences and phylogenetic analysis are available on GitHub at the following link: https://github.com/lauringlab/SARS2_Fall_2020.